Evidence map›Paper›PMID 31318857›Full record

ArticlePLoS neglected tropical diseases2019

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

Robert Colebunders, Joseph Nelson Siewe Fodjo, Adrian Hopkins, An Hotterbeekx, Thomson L Lakwo, Akili Kalinga, Makoy Yibi Logora, Maria-Gloria Basáñez

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Robert ColebundersGlobal Health Institute, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-1919-1340
Joseph Nelson Siewe FodjoGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Adrian HopkinsNeglected and Disabling Diseases of Poverty Consultant, Kent, United Kingdom.
An HotterbeekxGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Thomson L LakwoNeglected Tropical Diseases Control Programme, Ministry of Health, Kampala, Uganda.
Akili KalingaNational institute for Medical Research, Ministry of Health, Dar es Salaam, Tanzania.
Makoy Yibi LogoraNeglected Tropical Diseases Unit, Ministry of Health, Juba, South Sudan.
Maria-Gloria BasáñezLondon Centre for Neglected Tropical Disease Research and MRC Centre for Global Infectious Disease Analysis (MRC-GIDA), Imperial College London, London, United Kingdom.

Funding

Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiparasitic AgentsBlindnessCost of IllnessDisease EradicationEpilepsyHumansIvermectinNeglected DiseasesOnchocerciasisOnchocerciasis, OcularRiversAntiparasitic AgentsIvermectin

Identifiers

PMID31318857
PMCPMC6638735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.